The Next Quantum Leaps in Medtech
February 19th, 2020
8:00 - 8:40am
In his keynote address, Christopher Velis, founder of Auris Health and Miraki Innovation shares insights on a repeatable process for quantum leaps of innovation. As challenges in global healthcare increase and become more urgent, momentous progress is critical. Next generation medtech companies must think beyond incremental progress while also developing lifesaving companies without missteps or delay. Auris Health was the largest medtech venture funded transaction in history, acquired by Johnson & Johnson for a total of $5.75 billion. Christopher’s method, used to develop Auris and other leading medtech companies, identifies future demands and efficiently and effectively builds the solutions to those pressing market needs. Christopher discusses the Auris story and where he sees the next big opportunities (and challenges) in medtech innovation.
Christopher J. Velis
Founder & Executive Chairman, Miraki Innovation
Keynote
Interview with a Medtech Legend
February 18th, 2020
7:00 - 7:30pm
Join us for a fireside chat with industry legend and prolific entrepreneur, Dr. Manny Villafaña . We'll hear the stories and insights behind how Manny built St. Jude Medical, ATS Medical, and Cardiac Pacemakers Inc. We'll also find out what he's up to with his next venture, Medical 21.
Manny is the co-inventor of the first lithium powered pacemaker and founder of Cardiac Pacemakers, Inc./Guidant. He is the co-developer of the St. Jude heart valve, Founder of St. Jude Medical, Inc, co-inventor of the ATS heart valve, Founder of ATS Medical, Inc (Medtronic). Manny currently serves as the Founder, Chairman, & CEO of Medical 21, Inc. Dr. Villafaña is globally recognized as a “Living Legend of Medicine.” He is an award-winning USA Master Entrepreneur, a member of the Halls of Fame of Minnesota Business and Science & Technology. He is the past founder of medical device companies that have transformed the industry of cardiac surgery and improved the lives of millions. Manny is also the recipient of an honorary Doctorate of Sciences degree from the University of Iowa.
Manny Villafaña, PhD, Sc
Founder of St. Jude Medical, ATS, Cardiac Pacemakers, Currently CEO of Medical 21
Fireside Chat
Medtech 2020: Venture Capital Outlook
February 18th, 2020
7:40 - 8:25pm
In this panel we'll talk to active VCs about the types of deals they are in now and we'll find out what new deals they are looking for in 2020.
Dennis McWilliams
Venture Partner, Sante Ventures
Panelist
Jon Root
General Partner, US Venture Partners
Panelist
John F. Ryan
Managing Director, Wells Fargo Strategic Capital
Panelist
Janelle Goulard
Director of Health Investment, Pangaea Ventures
Panelist
Mar Perez
Principal, InCube Ventures
Panelist
Howard Levin, MD
Managing Partner, Coridea
Panelist
Bill Carpou
CEO, Octane
Moderator
Insights and Opinions From Big Company Executives Turned Entrepreneurs
February 19th, 2020
1:05 - 1:45pm
In this panel we’ll hear the experiences and insights from ex- big company executives who’ve chosen the entrepreneurial path and are now leading early stage medtech ventures. We’ll have them share war stories, perspectives of being on both sides of the table, and find out what they are up to next -- and why. The executives on this panel have held senior positions with the some of the largest medtech strategics and have multiple exits under their belts as entrepreneurs.
Join us for an informative (and fun) discussion with panelists Jim Corbett (Boston Scientific, ev3, MicroTherapeutics, Alphatec Spine), Todd Usen (Olympus, Smith & Nephew, Boston Scientific), Brian Verrier (Covidien, Medtronic), Paul Molloy (Telefex, VasoNova, Micardia), and Tim Moran (ConvaTec, Covidien).
The panel will be moderated by industry insider and Alira Health Senior Partner & VP, David Uffer.
Jim Corbett
CEO, CathWorks
Panelist
Brian Verrier
CEO, Ossio
Panelist
Todd Usen
CEO, Activ Surgical
Panelist
Timothy P. Moran
CEO, Motus GI
Panelist
Paul Molloy
CEO, ClearFlow
Panelist
David Uffer
Senior Partner & VP, Alira Health
Moderator
Future Trends in Medtech Innovation: 2020 Vision
February 20th, 2020
8:00 - 8:40am
Noam Krantz
Vice President, Venture Investments - Medical Devices, JJDC
Panelist
Greg Madden
Partner, SV Health Investors
Panelist
Stephen Ralph
Innovation Leader, W.L. Gore & Associates
Panelist
Michael Pereira
President & COO, Ximedica
Panelist
Lisa Carmel
Vice President of Business Development, Ximedica
Moderator
The Strategic Outlook on Medtech Deal-Making
February 19th, 2020
11:30am - 12:10pm
In this panel we'll get insights from leading medtech strategics J&J, Medtronic, Terumo, and Intuitive Surgical. We will discuss the types of deals they are looking for and have each stakeholder weigh in on deal structure trends and provide a perspective on where they see M&A in 2020 and beyond.
We will also learn about an important global strategic partnership formed in 2019 between Terumo & Orchestra BioMed and how this innovative approach to risk/reward sharing for product development and commercialization might shape future deal-making opportunities for strategics and innovators.
James Rushworth
CEO, Terumo Medical Corporation
Panelist
Nicholas Pachuda
WW VP, Orthopedic Innovation, J&J Medical Devices
Panelist
Julian Nikolchev
Senior VP Corporate Development & Strategy, Intuitive Surgical
Panelist
David Hochman
Chairman & CEO, Orchestra BioMed
Panelist
Earl Slee
VP, Technology, Strategy & Business Development, Medtronic
Panelist
Dave Mildrew
Managing Director, BioQuest
Moderator
2020: Hot Topics in Clinical Affairs
February 20th, 2020
Noon - 1pm
Saving money, speeding enrollment and generating real world evidence in clinical studies. Hear from industry experts, Ori Ben-Yehuda, MD, Tonya Dowd & Lisa Beck, about how to efficiently manage a clinical trial and generate real world evidence to support reimbursement and regulatory decisions.
This panel discussion will be hosted by MCRA and will run during a lunch session. Space is limited. To reserve your spot, please RSVP here.
Lisa Beck
Director, Clinical Affairs, MCRA
Moderator
Ori Ben-Yehuda
Executive Director, Cardiovascular Research Foundation
Panelist
Tonya Dowd
Vice President, MCRA
Panelist
Early Reimbursement & Market Access Planning: Not Optional
February 18th, 2020
Noon - 1:00pm
In this panel we'll get a "from the trenches" perspective on reimbursement and market access strategies directly from the key stakeholders; the CEO, Strategic Investor, Venture Capitalist, and Payer. This group will share their insights and experiences (some positive, some painful) on why having a proper reimbursement and market access strategy is so critical.
The panel will be moderated by medtech industry veteran and reimbursement thought leader, Tonya Dowd. Tonya is MCRA's Vice President of Reimbursement, Health Economics and Market Access.
Terri Burke
Venture Partner, Epidarex Capital
Insights from the VC
Lisa Wipperman Heine
CEO, PreCardia
Insights from the CEO
Tonya Dowd
Vice President, MCRA
Moderator
Gary Owens, M.D.
Medical Director, Former Payer
Insights from the Payer
Non-Traditional VC, Family Office, Angel & CrowdSourcing in 2020
February 20th, 2020
1:05 - 1:45pm
In this panel we’ll hear from active medtech angels, family office, and other non-traditional early stage investors. What are they investing in? What are they bringing to the table besides capital? What kind of deals are they interested in right now?
This group of panelists represent a new CrowdSourcing & Direct Investment Platform, 4 Lifescience Angel Groups, 2 Family Offices, and a new VC fund focused exclusively on early-stage deals.
Rob Ball
Managing Director, Genesis & CultivateMD Fund
Panelist
Greg Scott
Co-Founder, BioPacific Investors, Chairman, ChinaBio Group
Panelist
Brian Smith
CEO, RedCrow, Direct Investment Platform
Panelist
Ben Joseph
President, Mend Medical
Panelist
Irfan Lateef
Partner, Knobbe Martens
Moderator
David Hood
President, DH3 & Associates
Panelist
Health Economics and Outcomes Research (HEOR): From Concept to Implementation
February 20th, 2020
11:20am - 12:00pm
This panel will introduce the audience to Health Economics and Outcomes Research (HEOR) fundamentals, how HEOR strategies can be implemented at the different stages of product development, and how to use HEOR to drive value at each stage of the development lifecycle.
Scott Tackett
Vice President - Global Access, Value & Economics, Intuitive Surgical
Panelist
Michael Neidert
VP of Business Development, Ximedica
Panelist
Dr. Jo Carol Hiatt
Emeritus, National Product Council; Chair, Inter-Regional New Technologies Committee, Kaiser Permanente
Panelist
Deepak Sahu
Manager, Alira Health
Moderator
Seth Clancy
VP, Global Health Economics & Reimbursement, Edwards Lifesciences
Panelist
Navigating Medtech QA & RA Hurdles in 2020
February 19th, 2020
Noon - 1pm
This working lunch session will be hosted by E.M.M.A. International Consulting. There is limited space for this session. To reserve your spot, RSVP here.
QMS challenges are not limited to start ups. Using EMMA International’s proprietary methodology, companies are able to implement a quality management system that is; Compliant, Lean, Integrated, and Customizable (CLIC).
Topics Addressed:
- Overview of regulatory requirements from FDA, ISO 13485, ISO 14971 & EU MDR
- Common Mistakes Companies Make
- Overview of CLIC
- Technical, financial, and operational challenges for implementing a QMS
- How to assess your QMS needs/current system
- Financial Investment vs Financial Disaster
- Case studies/success stories from EMMA International
Carmine Jabri
President, E.M.M.A. International Consulting Group
Lunch Speaker
